NewAmsterdam Pharma

Biotech · Public

Obicetrapib, an oral CETP inhibitor small-molecule drug for lowering LDL cholesterol

newamsterdampharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2922AADI, LLC——
2923NAUTILUS, INC.——
2924CULNEXIN THERAPEUTICS LLC——
2925NewAmsterdam Pharma——
2926TRPBLUE, INC.——
2927Senotrac Biotechnology LLC——
2928ILUMINOS THERAPEUTICS LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.